Chemotherapy induced reversible posterior leukoencephalopathy syndrome

Lung Cancer

Volumn 56, Issue 3, 2007, Pages 459-463

  Connolly, Roisin M ^a   Doherty, Colin P ^a   Beddy, Peter ^a   O'Byrne, Ken ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

Chemotherapy; Cisplatin; Encephalopathy; Gemcitabine; Lung malignancy; Seizures

Indexed keywords

CISPLATIN; GEMCITABINE; HYDRALAZINE; LABETALOL; MAGNESIUM SULFATE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL EVALUATION; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; FEMALE; HUMAN; HYPERTENSION; LEUKOENCEPHALOPATHY; LUNG NON SMALL CELL CANCER; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RADIOLOGICAL PROCEDURES;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DEOXYCYTIDINE; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MENINGEAL NEOPLASMS; MIDDLE AGED; RIBONUCLEOTIDE REDUCTASES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34247625479     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.01.012     Document Type: Article

References (21)

1. Hinchey J., Chaves C., Appignani B., Breen J., Pao L., Wang A., et al. A reversible posterior leukoencephalopathy syndrome. NEJM 334 (1996) 494-500
2. Hauser R.A., Lacey D.M., and Knight M.R. Hypertensive encephalopathy: magnetic resonance imaging demonstration of reversible cortical and white matter lesions. Arch Neurol 45 (1988) 1078-1083
3. Raroch Jr. H.G., Orrison W.W., and Rosenberg G.A. Neurologic involvement in toxaemia of pregnancy: reversible MRI lesions. Neurology 40 (1990) 167-169
4. Tam C.S., Galanos J., Seymour J.F., Pitman A.G., Stark R.J., and Prince H.M. Reversible posterior leucoencephalopathy syndrome complicating cytotoxic chemotherapy for haematological malignancies. Am J Haematol 77 (2004) 72-76
5. Port J.D., and Beauchamp Jr. N.I. Reversible intracerebral pathological entities mediated by vascular autoregulatory dysfunction. RadioGraphics 18 (1998) 353-367
6. Schwartz B. A reversible posterior leucoencephalopathy syndrome [letter]. NEJM 334 (1996) 1743
7. Casey S., Sampaio R., Michel E., and Truwit C. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. Am J Neuroradiol 21 (2000) 1199-1206
8. Dinsdale H.B., Robertson D.M., and Haas R.A. Cerebral blood flow in acute hypertension. Eur Neurol 31 (1974) 80-87
9. Kawai H., Nakamura H., Sanada M., Kitahara S., and Maeda K. Microhemorrhages in a patient with reversible posterior leukoencephalopathy syndrome. Neurology 67 9 (2006) 1712
10. Briellmann R.S., Wellard R.M., and Jackson G.D. Seizure-associated abnormalities in epilepsy: evidence from MR imaging. Epilepsia 46 5 (2005) 760-766
11. Shutter L.A., Green J.P., Newman N.J., Hooks M.A., and Gordon R.D. Cortical blindness and white matter lesions in a patient receiving FK506 after liver transplantation. Neurology 43 (1993) 2417-2418
12. Merimsky O., and Chaitchik S. Neurotoxicity of intereferon-alpha. Anticancer Drugs 3 (1992) 567-570
13. Vaughn D.J., Jarvik J.G., Hackney D., Peters S., and Stadtmauer E.A. High-dose cytarabine neurotoxicity: MR findings during the acute phase. Am J Neuroradiol 14 (1993) 1014-1016
14. Gorman D., Kefford R., and Stuart-Harris R. Focal encephalopathy after cisplatin therapy. Med J Aust 150 (1989) 399-401
15. Russell M.T., Nassif A.S., Cacayorin E.D., Awwad E., Perman W., and Dunphy F. Gemcitabine-associated posterior reversible encephalopathy syndrome: MR imaging and MR spectroscopy findings. MRI 19 (2001) 129-132
16. Ozcan C., Wong S.J., and Hari P. Reversible posterior leucoencephalopathy syndrome and bevacizumab. NEJM 354 9 (2006) 980-982
17. Govindarajan R., Adusumilli J., Baxter D.L., El-Khoueiry A., and Harik S.I. Reversible posterior leukoencephalopathy syndrome induced by RAF kinase inhibitor BAY 43-9006. JCO 24 28 (2006) e48
18. Doll D.C., Ringenberg Q.S., and Yarbro J.W. Vascular toxicity associated with antineoplastic agents. JCO 4 (1986) 1405-1417
19. Hennessy B., O'Connor M., and Carney D.N. Acute vascular events associated with cisplatin therapy in malignant disease. Ir Med J 95 5 (2002) 145-6, 148
20. Numico G., Garrone O., Dongiovanni V., Silvestris N., Colantonio I., Di Costanzo G., et al. Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine. Cancer 103 5 (2005) 994-999
21. Parkin D.M., Pisani P., and Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54 4 (1993) 594-606